Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erica Moretti

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Biomolecules|December 18, 2020
Cell-Free DNA-Methylation-Based Methods and Applications in OncologyFrancesca Galardi, Francesca De Luca, Dario Romagnoli, et al.
Cancer Treatment Reviews|January 17, 2013
Targeting triple negative breast cancer: is p53 the answer?Natalie Turner, Erica Moretti, Olimpia Siclari, et al.
Future Oncology (London, England)|October 11, 2013
TOP2A protein by quantitative immunofluorescence as a predictor of response to epirubicin in the neoadjuvant treatment of breast cancerErica Moretti, Christine Desmedt, Chiara Biagioni, et al.
NPJ Breast Cancer|March 8, 2025
Enabling sensitive and precise detection of ctDNA through somatic copy number aberrations in breast cancerRiccardo Scandino, Agostina Nardone, Nicola Casiraghi, et al.
Briefings in Bioinformatics|January 18, 2023
MIMESIS: minimal DNA-methylation signatures to quantify and classify tumor signals in tissue and cell-free DNA samplesDario Romagnoli, Agostina Nardone, Francesca Galardi, et al.
Cancer|February 29, 2012
Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patientsEun-Jung Jung, Libero Santarpia, Juyeon Kim, et al.
JCO Precision Oncology|March 1, 2024
Mutational Analysis of Circulating Tumor DNA in Patients With Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer Receiving Palbociclib: Results From the TREnd TrialIlenia Migliaccio, Dario Romagnoli, Francesca Galardi, et al.
Translational Oncology|November 20, 2022
Risk assessment of disease recurrence in early breast cancer: A serum metabolomic study focused on elderly patientsEmanuela Risi, Camilla Lisanti, Alessia Vignoli, et al.
Genome Medicine|February 4, 2026
A computational framework for sensitive tumor detection and accurate subtyping using shallow cell-free DNA methylome sequencingMarta Paoli, Francesca Galardi, Agostina Nardone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2020
Plasma Thymidine Kinase Activity as a Biomarker in Patients with Luminal Metastatic Breast Cancer Treated with Palbociclib within the TREnd TrialAmelia McCartney, Martina Bonechi, Francesca De Luca, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Biomolecules|December 18, 2020
Cell-Free DNA-Methylation-Based Methods and Applications in OncologyFrancesca Galardi, Francesca De Luca, Dario Romagnoli, et al.
Cancer Treatment Reviews|January 17, 2013
Targeting triple negative breast cancer: is p53 the answer?Natalie Turner, Erica Moretti, Olimpia Siclari, et al.
Future Oncology (London, England)|October 11, 2013
TOP2A protein by quantitative immunofluorescence as a predictor of response to epirubicin in the neoadjuvant treatment of breast cancerErica Moretti, Christine Desmedt, Chiara Biagioni, et al.
NPJ Breast Cancer|March 8, 2025
Enabling sensitive and precise detection of ctDNA through somatic copy number aberrations in breast cancerRiccardo Scandino, Agostina Nardone, Nicola Casiraghi, et al.
Briefings in Bioinformatics|January 18, 2023
MIMESIS: minimal DNA-methylation signatures to quantify and classify tumor signals in tissue and cell-free DNA samplesDario Romagnoli, Agostina Nardone, Francesca Galardi, et al.
Cancer|February 29, 2012
Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patientsEun-Jung Jung, Libero Santarpia, Juyeon Kim, et al.
JCO Precision Oncology|March 1, 2024
Mutational Analysis of Circulating Tumor DNA in Patients With Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer Receiving Palbociclib: Results From the TREnd TrialIlenia Migliaccio, Dario Romagnoli, Francesca Galardi, et al.
Translational Oncology|November 20, 2022
Risk assessment of disease recurrence in early breast cancer: A serum metabolomic study focused on elderly patientsEmanuela Risi, Camilla Lisanti, Alessia Vignoli, et al.
Genome Medicine|February 4, 2026
A computational framework for sensitive tumor detection and accurate subtyping using shallow cell-free DNA methylome sequencingMarta Paoli, Francesca Galardi, Agostina Nardone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2020
Plasma Thymidine Kinase Activity as a Biomarker in Patients with Luminal Metastatic Breast Cancer Treated with Palbociclib within the TREnd TrialAmelia McCartney, Martina Bonechi, Francesca De Luca, et al.
Pageof 4